# Risedronate Sodium

NDC: 60723-041
Generic name: Risedronate Sodium
Labeler / Manufacturer: Hangzhou Minsheng Binjiang Pharmaceutical CO., Ltd
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20190401

FDA application: ANDA207516

## Active ingredients

- RISEDRONATE SODIUM HEMI-PENTAHYDRATE: 35 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"60723-041"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=60723-041
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d60a56cb-ef49-4447-9043-7b6879a20d75